The store will not work correctly when cookies are disabled.
US8822447, 171
ID: ALA3666183
PubChem CID: 86767158
Max Phase: Preclinical
Molecular Formula: C23H18N4OS
Molecular Weight: 398.49
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CSc1nn(-c2ccccc2)c2cc(C(=O)c3ccc4ncn(C)c4c3)ccc12
Standard InChI: InChI=1S/C23H18N4OS/c1-26-14-24-19-11-9-16(13-21(19)26)22(28)15-8-10-18-20(12-15)27(25-23(18)29-2)17-6-4-3-5-7-17/h3-14H,1-2H3
Standard InChI Key: QOUCAALJAAZEFV-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 33 0 0 0 0 0 0 0 0999 V2000
-0.3167 -5.2226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6890 -4.0818 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
0.3114 -2.9665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8032 -3.1233 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.4133 -1.7530 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8813 -1.4408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9619 -2.4739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4015 -2.0524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7561 -0.5949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6713 0.4410 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2318 0.0194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0031 3.0008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0351 3.6026 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.3039 3.7494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3092 5.2494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6108 5.9949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9073 5.2404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.3346 5.6990 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-6.2121 4.4824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.3262 3.2720 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.6930 2.1294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9021 3.7404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6005 2.9949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
5 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 3 1 0
17 12 1 0
14 18 1 0
18 19 2 0
18 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 1 0
26 28 1 0
28 23 1 0
28 29 2 0
29 20 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 398.49 | Molecular Weight (Monoisotopic): 398.1201 | AlogP: 4.87 | #Rotatable Bonds: 4 |
Polar Surface Area: 52.71 | Molecular Species: NEUTRAL | HBA: 6 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 5.07 | CX LogP: 5.27 | CX LogD: 5.27 |
Aromatic Rings: 5 | Heavy Atoms: 29 | QED Weighted: 0.32 | Np Likeness Score: -1.13 |
References
1. (2014) Indazole compounds useful as ketohexokinase inhibitors, |